The company reported $80.2 million in cash and equivalents as of March 31, up from $76.9 million at year-end 2025.
Alpha Tau Medical reported cash and cash equivalents, short-term deposits, and restricted deposits totaling $80.2 million as of March 31, 2026. This marks an increase from $76.9 million recorded at December 31, 2025.
The rise in liquid assets follows the company’s latest financial period, though GAAP EPS remained negative at -$0.26. No prior consensus estimates were provided for comparison.
Market reaction details were not disclosed in the release.